Business
A new app which collates older people’s health indicators and monitors for flu symptoms supports nurses and carers to make remote diagnoses and treat patients in their homes, reducing hospitalisations.
The company said its valuation is now $1.4 billion.
The latest round follows a $14 million Series B raise from 2019.
The company said the Series B brings its total raise to $20 million.
The company plans to put the new funds towards building out its platform.
The company said it’s app analyzes weekly urine tests to provide nutrition and lifestyle guidance.
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
This new infusion of cash brings the company's total funding to $28 million.
The companies said their collaboration will improve access to care, particularly for those who would benefit from additional in-person care.
The new technology is being developed for in-hospital and at-home use.